Telmisartan
Micardis
Angiotensin 2 Receptor Blocker
NADAC/unit
$0.1044
No Shortage
Tier 1: 187.2%
16 Manufacturers
48 ANDAs
Telmisartan lowers blood pressure by blocking angiotensin II receptors, used for hypertension and kidney protection.
vs. brand Micardis: Generic saves up to 99% per unit
Market Intelligence
2024-03-20 Class II Recall: Micro Labs Limited
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAMNEAL PHARMACEUTICALSAUROBINDO PHARMA LTDBOEHRINGER INGELHEIMCADILA PHARMACEUTICALS LTDCHARTWELL RX SCIENCES LLCGLENMARK PHARMACEUTICALS LTDINVENTIA HEALTHCARE LTDJUBILANT GENERICS LTDMACLEODS PHARMACEUTICALS LTDMANKIND PHARMA LTDMICRO LABS LTDMYLAN PHARMACEUTICALS INCPRINSTON PHARMACEUTICAL INCSANDOZ INCTORRENT PHARMACEUTICALS LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.